Lactulose is available over the counter in many countries, including the United Kingdom, Canada, Australia, and much of continental Europe, but it requires a prescription in the United States. This split confuses people who travel, shop online, or read health advice written for a different market. The reason for the discrepancy has less to do with safety concerns and more to do with how lactulose was originally approved in the US and the regulatory inertia that followed.
Why the US Requires a Prescription
When lactulose first entered the US market in the 1970s, it was approved as a prescription drug for constipation and, separately, for the treatment of hepatic encephalopathy, a serious neurological complication of advanced liver disease. Because the same molecule serves both a relatively mild purpose (softening stool) and a critical medical one (lowering toxic ammonia levels in the blood), the Food and Drug Administration classified it as prescription-only, and that classification has never been revisited. Hepatic encephalopathy is a condition brought on by liver dysfunction, where toxins like ammonia accumulate and impair brain activity, and managing it requires medical oversight, dose titration, and lab monitoring.
1Pakistan Journal of Health Sciences. Comparing Probiotics Plus Lactulose with Lactulose Alone in Treatment of Overt Hepatic EncephalopathyIn countries where lactulose is sold over the counter, it is typically available in smaller package sizes intended for short-term relief of constipation. Higher-dose or longer-term use for liver disease still requires a prescription or pharmacist consultation in most of those markets. So the difference between the US and the rest of the world is not really about whether lactulose is safe enough for self-treatment of constipation. It is about a decades-old regulatory decision that bundled two very different uses under one classification.
How Lactulose Works
Lactulose is a synthetic sugar that your body cannot digest. It passes through the stomach and small intestine intact and arrives in the colon, where gut bacteria ferment it. That fermentation produces short-chain fatty acids and lactic acid, which lower the pH inside the colon and draw water into the bowel through osmosis. The extra water softens stool and stimulates movement.
2PubMed Central. Review of history and mechanisms of action of lactulose (4-O-β-D-Galactopyranosyl-β-D-fructofuranose): present and future applications in foodFor hepatic encephalopathy, the same acid-producing mechanism matters for a different reason. The lower pH in the colon converts ammonia into ammonium, a form that cannot cross back into the bloodstream as easily. The osmotic effect also speeds transit, giving the body less time to absorb ammonia. The result is that blood ammonia levels drop, and the patient’s mental state improves. This dual mechanism is why lactulose has stayed relevant for decades despite newer alternatives.
What Lactulose Treats
The two main medical uses are chronic constipation and hepatic encephalopathy. For constipation, lactulose is typically taken at lower doses, usually around 15 to 30 milliliters a day for adults. A multicenter trial comparing lactulose to stimulant laxatives found that by the seventh day, about 58 percent of lactulose-treated patients were passing normal stool, versus 42 percent of those on stimulant laxatives. Lactulose also showed a carry-over effect after treatment stopped, meaning bowel function continued to improve even after patients quit taking it.
3PubMed. Comparison of “Duphalac” and “irritant” laxatives during and after treatment of chronic constipation: a preliminary studyFor hepatic encephalopathy, doses are much higher and more frequent, sometimes 30 to 45 milliliters taken three or four times a day, adjusted until the patient has two to three soft stools daily. This is not self-care territory. Patients on these doses need regular blood work and close medical follow-up, which is one reason the US prescription requirement makes more sense for liver patients than for someone dealing with occasional constipation.
If You Are in the US and Want It for Constipation
You need a prescription from a doctor, nurse practitioner, or other prescriber. Generic lactulose solution is widely available and inexpensive, often costing under $20 for a large bottle even without insurance. Many telehealth platforms can prescribe it after a brief consultation, so you do not necessarily need an in-person visit. If your main concern is garden-variety constipation, though, your provider may steer you toward polyethylene glycol (commonly sold as MiraLAX), which is already available over the counter in the US and works through a similar osmotic mechanism.
The reason MiraLAX went OTC while lactulose did not is partly commercial and partly regulatory. The manufacturer of MiraLAX pursued the switch from prescription to over-the-counter status and received FDA approval for it. No manufacturer has done the same for lactulose in the US market, so it remains locked behind a prescription by default rather than by ongoing safety concern.
How Lactulose Compares to Polyethylene Glycol
Since polyethylene glycol (PEG) is the most common OTC osmotic laxative in the US, the comparison matters if you are deciding whether to ask your doctor for lactulose or simply buy PEG at a pharmacy. A Cochrane systematic review looking at chronic constipation concluded that PEG outperformed lactulose on several measures, including stool frequency per week, stool form, relief of abdominal pain, and the need for additional products. That advantage held in both adults and children, except for abdominal pain relief in children, where the two were similar.
4PubMed Central. Lactulose versus Polyethylene Glycol for Chronic ConstipationA randomized trial in children specifically found that at 12 weeks, good clinical outcomes were achieved in 98 percent of the PEG group and 90 percent of the lactulose group. The PEG group also had more bowel movements per week on average. Side effects like bloating and abdominal pain were actually more common in the lactulose group.
5PubMed. PEG 3350 Versus Lactulose for Treatment of Functional Constipation in Children: Randomized StudyA study of children with cerebral palsy found a similar pattern: PEG produced higher success rates at both 12 weeks (57 percent vs. 33 percent) and 24 weeks (62 percent vs. 37 percent) compared to lactulose.
6PubMed Central. Constipation in Children with Cerebral Palsy: Prevalence, Clinical Manifestations, and Polyethylene glycol vs. Lactulose EfficacySo if the question is strictly about relieving constipation, PEG tends to come out ahead in the research. Lactulose still has its defenders, though, because of its prebiotic properties and carry-over effect, and some patients simply respond better to it. Medicine is not always about the average.
The Prebiotic Angle
One area where lactulose has an edge that PEG does not is its effect on gut bacteria. Because it is fermented by specific microbes in the colon, lactulose selectively promotes the growth of health-associated bacteria, particularly Bifidobacterium and Lactobacillus species. Multiple preclinical and clinical studies have confirmed this, along with an increase in short-chain fatty acid production and a reduction in certain potentially harmful bacteria.
7PubMed Central. Low-Dose Lactulose as a Prebiotic for Improved Gut Health and Enhanced Mineral AbsorptionNewer research has gotten more specific. Incubation of human donor stool samples with lactulose showed growth stimulation of a restricted set of bacterial groups, most prominently Bifidobacterium, Collinsella, and Lactococcus.
8PubMed Central. Lactulose selectively stimulates members of the gut microbiota, as determined by multi-modal activity-based sortingThis is why in some countries, particularly in Europe and Japan, low-dose lactulose is marketed not just as a laxative but as a functional food ingredient or prebiotic supplement. At these lower doses, the laxative effect is minimal, but the shift in gut bacteria composition still occurs. PEG, by contrast, is not fermented by gut bacteria and has no prebiotic properties. It is purely an osmotic agent.
Side Effects and Safety Concerns
At typical constipation doses, lactulose is considered quite safe. The most common complaints are gas, bloating, and abdominal cramps, all of which stem from the fermentation process in the colon. These side effects tend to improve after the first few days as the gut adjusts, but they are a real reason some people abandon the medication. A randomized trial in children found that lactulose treatment improved stool frequency and consistency after six weeks with no significant adverse events compared to placebo, though flatulence and abdominal pain scores were similar between the two groups.
9PubMed Central. Lactulose for the treatment of Chinese children with chronic constipation: A randomized controlled trialThe serious safety issues arise almost exclusively at higher doses used in hospital settings for hepatic encephalopathy. Because lactulose pulls water into the bowel, aggressive dosing can cause enough fluid loss to concentrate sodium in the blood. In one study of hospitalized patients, elevated sodium levels developed in about a quarter of lactulose treatment courses, and patients who became hypernatremic had substantially higher mortality than those who did not.
10PubMed. Hypernatremia and lactulose therapyIn extreme cases, the sodium spike from lactulose-induced dehydration has triggered osmotic demyelination syndrome, a rare but devastating brain injury. A case report described a patient with chronic alcoholism who developed confusion after five days of lactulose enemas, with sodium climbing to dangerously high levels.
11PubMed Central. Osmotic Demyelination Syndrome Associated with Hypernatremia Caused by Lactulose Enema in a Patient with Chronic AlcoholismThese are hospital complications in very sick patients receiving large and frequent doses, not risks you would face taking a tablespoon of lactulose for constipation. But they illustrate why the hepatic encephalopathy indication genuinely requires medical supervision and why self-dosing at high levels is a bad idea regardless of where you live.
Children and Lactulose
Lactulose has a long track record in pediatric use and is one of the more commonly prescribed laxatives for children in many countries. Studies have shown it restores normal bowel habits, softens stool, and reduces pain in constipated children.
12PubMed Central. Lactulose versus polyethylene glycol for disimpaction therapy in constipated children, a randomized controlled studyIn countries where lactulose is available over the counter, parents can purchase it directly for their child. In the US, a pediatrician would need to prescribe it, though many doctors default to PEG instead because of the stronger evidence base and the fact that parents can buy it without a visit. For children who do not tolerate PEG or whose parents prefer a product with prebiotic properties, lactulose remains a reasonable and well-studied alternative. One randomized trial found that all constipated children in both the lactulose and PEG groups achieved successful disimpaction by the seventh day, with no significant adverse events reported in either group.
12PubMed Central. Lactulose versus polyethylene glycol for disimpaction therapy in constipated children, a randomized controlled studyLactulose and Blood Sugar
Because lactulose is a synthetic sugar, people with diabetes sometimes worry about blood glucose spikes. The concern is understandable but largely unfounded at normal doses. A controlled study in people with type 2 diabetes found that lactulose did not significantly affect the overall blood glucose response compared to plain water, regardless of dose or formulation. The one exception was a minor increase in peak blood glucose after a 30-gram liquid dose, amounting to a difference of about 0.63 mmol/L compared to water. That 30-gram dose is at the very top end of what anyone would take for constipation, and the effect was small.
13PubMed Central. Blood glucose response after oral lactulose intake in type 2 diabetic individualsThe reason lactulose has minimal glycemic impact is the same reason it works as a laxative: human enzymes cannot break it down into absorbable simple sugars. It passes through your digestive tract to the colon intact. Gut bacteria do eventually metabolize it, but the end products are organic acids, not glucose.
The Taste Problem
Anyone who has taken lactulose syrup knows it is cloyingly sweet, sometimes unpleasantly so. This is not a trivial issue. For patients with liver disease who need to take large volumes multiple times a day, the taste is a genuine barrier to sticking with the medication. Researchers studying adherence in patients with cirrhosis and hepatic encephalopathy have noted that the frequent dosing and large volumes of lactulose syrup create real compliance challenges, and the excessively sweet taste makes things worse.
14PubMed Central. Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic EncephalopathyLactulose is currently available only as a liquid syrup in most markets, including the US. A jelly formulation tested in Japan showed improved palatability compared to the commercial syrup, but it has not become widely available outside Japan. Common workarounds include mixing lactulose into cold juice, diluting it with water, or chilling it before use. None of these are perfect solutions, but they help. For constipation patients taking smaller doses, the taste is more tolerable, and mixing it into a glass of water or juice is usually enough to make it manageable.
14PubMed Central. Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic EncephalopathyLactulose in Breath Testing
Beyond its use as a laxative and a treatment for liver disease, lactulose serves a completely different role in gastroenterology: as a test substrate for diagnosing small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth. In a lactulose breath test, you drink a dose of lactulose and then breathe into collection tubes at regular intervals. If bacteria in your small intestine ferment the lactulose before it reaches the colon, the resulting hydrogen or methane shows up in your breath earlier than expected.
15PubMed. Diagnostic Reliability of Glucose and Lactulose Breath Tests: Insights From a Test-Retest Study in Healthy AdultsThe test is widely used, but its accuracy is a legitimate concern. A systematic review with meta-analysis found that when compared against the gold standard of jejunal culture, the lactulose breath test had a pooled sensitivity of only about 42 percent and a specificity of about 71 percent. In plain terms, the test misses more than half of true SIBO cases and also flags some people who do not actually have it. Clinicians still use it because noninvasive options are limited, but a negative lactulose breath test does not rule out SIBO, and a positive one does not confirm it beyond doubt.
16Journal of Neurogastroenterology and Motility. Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysisIf you have been prescribed a lactulose breath test and are wondering whether the lactulose used for the test is the same product sold for constipation, the answer is yes. It is the same molecule. The dose is typically 10 grams dissolved in water, smaller than a therapeutic laxative dose but enough to produce a measurable gas response if bacteria are fermenting it in the wrong place.